Skip to content

Sichenzia Ross Friedman Ference LLP Advises Trovagene Inc. on a $23.0M Public Offering

Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $28.7M Public Offering

Full Swing Golf Announces Endorsement Deal with Tiger Woods

Vuzix Corp. Announces $24.8M Investment from Intel

PlasmaTech Announces $14.0 M Public Offering and NASDAQ Listing

SBI Investments Announces $6.5 Million Private Placement

Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering

Sichenzia Ross Friedman Ference Advises MV Agusta on Partnership with Mercedes-AMG

CEL-SCI Corporation Announces $6.0 Million Public Offering

Towerstream Corporation Announces $35.0 Million Secured Financing

Sichenzia Ross Friedman Ference LLP Advises Tonix Pharmaceuticals on $7.8 Million Public Offering

Sicheniza Ross Friedman Ference Advises Cell Source Ltd. on Reverse Merger

CollabRx, Inc.

Sichenzia Ross Friedman Ference LLP Advises NTS Inc. on $140.0 Million Acquisition Transaction

Sichenzia Ross Friedman Ference LLP Advises FreeSeas Inc. on $25.0 Million Public Offering of Preferred Stock and Warrants

Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Secondary Public Offering of Cyclacel Pharmaceuticals, Inc.

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc.

Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering

Sichenzia Ross Friedman Ference LLP Advises Brean Capital LLC on $ 6.5 million Registered Direct Offering of ClearSign Combustion Corporation